NASDAQ:QDEL QuidelOrtho (QDEL) Stock Price, News & Analysis → Radical change coming — do this NOW to protect yourself (From Weiss Ratings) (Ad) Free QDEL Stock Alerts $36.31 -0.14 (-0.38%) (As of 06/17/2024 ET) Add Compare Share Share Today's Range$35.40▼$36.5950-Day Range$36.31▼$44.9652-Week Range$35.40▼$89.11Volume1.08 million shsAverage Volume985,670 shsMarket Capitalization$2.43 billionP/E RatioN/ADividend YieldN/APrice Target$59.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get QuidelOrtho alerts: Email Address QuidelOrtho MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside62.5% Upside$59.00 Price TargetShort InterestHealthy4.35% of Shares Sold ShortDividend StrengthN/ASustainability-2.61Upright™ Environmental ScoreNews Sentiment0.32Based on 11 Articles This WeekInsider TradingSelling Shares$2.59 M Sold Last QuarterProj. Earnings Growth84.86%From $1.85 to $3.42 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.68 out of 5 starsMedical Sector51st out of 913 stocksDiagnostic Substances Industry1st out of 14 stocks 3.0 Analyst's Opinion Consensus RatingQuidelOrtho has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 2 buy ratings, 3 hold ratings, and 2 sell ratings.Amount of Analyst CoverageQuidelOrtho has only been the subject of 1 research reports in the past 90 days.Read more about QuidelOrtho's stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted4.35% of the outstanding shares of QuidelOrtho have been sold short.Short Interest Ratio / Days to CoverQuidelOrtho has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in QuidelOrtho has recently decreased by 11.82%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldQuidelOrtho does not currently pay a dividend.Dividend GrowthQuidelOrtho does not have a long track record of dividend growth. Previous Next 3.8 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreQuidelOrtho has received a 49.48% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Sexually transmitted diseases quick tests", "Lactose intolerance quick tests", and "Respiratory tract infection tests" products. See details.Environmental SustainabilityThe Environmental Impact score for QuidelOrtho is -2.61. Previous Next 2.4 News and Social Media Coverage News SentimentQuidelOrtho has a news sentiment score of 0.32. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.91 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 11 news articles for QuidelOrtho this week, compared to 6 articles on an average week.Search Interest4 people have searched for QDEL on MarketBeat in the last 30 days. MarketBeat FollowsOnly 4 people have added QuidelOrtho to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, QuidelOrtho insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,585,300.00 in company stock.Percentage Held by InsidersOnly 1.00% of the stock of QuidelOrtho is held by insiders.Percentage Held by Institutions99.00% of the stock of QuidelOrtho is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about QuidelOrtho's insider trading history. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for QuidelOrtho are expected to grow by 84.86% in the coming year, from $1.85 to $3.42 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of QuidelOrtho is -1.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of QuidelOrtho is -1.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioQuidelOrtho has a P/B Ratio of 0.48. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about QuidelOrtho's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Weiss RatingsRadical change coming — do this NOW to protect yourselfI recently uncovered a way the government could use the next crisis as a pretext to gain more control … and radically change life in America as we know it today. And a Draconian set of technologies that could impose a new kind of financial surveillance in America. Click here to learn more. About QuidelOrtho Stock (NASDAQ:QDEL)QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.Read More QDEL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart QDEL Stock News HeadlinesJune 16 at 4:34 AM | insidertrades.comCarlyle Group Inc. Sells 64,263 Shares of QuidelOrtho Co. (NASDAQ:QDEL) StockJune 17 at 1:12 AM | americanbankingnews.comBrokerages Set QuidelOrtho Co. (NASDAQ:QDEL) PT at $59.00June 16 at 2:32 AM | americanbankingnews.comQuidelOrtho (NASDAQ:QDEL) Hits New 52-Week Low on Insider SellingJune 15 at 6:32 AM | americanbankingnews.comQuidelOrtho (NASDAQ:QDEL) Trading Down 3.6%June 11, 2024 | globenewswire.comQuidelOrtho Corporation Investors Notice: Class action lawsuit filed on behalf of investors; the Portnoy Law FirmJune 11, 2024 | businesswire.comDEADLINE TODAY: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the FirmJune 10, 2024 | globenewswire.comDEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of QuidelOrthoJune 10, 2024 | prnewswire.comThe Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL) ShareholdersJune 10, 2024 | globenewswire.comQDEL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that QuidelOrtho Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!June 8, 2024 | globenewswire.comROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Secure Counsel Before Important June 11 Deadline in Securities Class Action – QDELJune 7, 2024 | globenewswire.comLevi & Korsinsky Reminds QuidelOrtho Corporation f/k/a Quidel Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 11, 2024 – QDELJune 6, 2024 | prnewswire.comQDEL Investors Have Opportunity to Lead QuidelOrtho Corporation Securities Fraud LawsuitJune 6, 2024 | globenewswire.comClass Action Filed Against QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL) Seeking Recovery for Investors – Contact The Gross Law FirmJune 6, 2024 | prnewswire.comSHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of QuidelOrthoJune 6, 2024 | prnewswire.comQDEL LAWSUIT ALERT: Levi & Korsinsky Notifies QuidelOrtho Corporation f/k/a Quidel Corporation Investors of a Class Action Lawsuit and Upcoming DeadlineJune 5, 2024 | prnewswire.comROSEN, A TOP RANKED LAW FIRM, Encourages QuidelOrtho Corporation Investors to Secure Counsel Before Important June 11 Deadline in Securities Class Action - QDELJune 5, 2024 | globenewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against QuidelOrtho Corporation – QDELJune 5, 2024 | globenewswire.comDEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of QuidelOrthoJune 5, 2024 | prnewswire.comClass Action Filed Against QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL) - June 11, 2024 Deadline to Join - Contact The Gross Law FirmJune 4, 2024 | globenewswire.comROSEN, A LEADING NATIONAL FIRM, Encourages QuidelOrtho Corporation Investors to Secure Counsel Before Important June 11 Deadline in Securities Class Action – QDELJune 4, 2024 | globenewswire.comContact Hagens Berman by June 11, 2024 Deadline to Join Class Action Against QuidelOrtho (QDEL)June 4, 2024 | prnewswire.comQuidelOrtho Corporation f/k/a Quidel Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - QDELJune 4, 2024 | globenewswire.comQUIDELORTHO CORPORATION (NASDAQ: QDEL) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against QuidelOrtho CorporationJune 3, 2024 | globenewswire.comQuidelOrtho Corporation Investors Notice: Class action lawsuit filed on behalf of investors; the Portnoy Law FirmJune 3, 2024 | globenewswire.comQDEL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that QuidelOrtho Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!See More Headlines Receive QDEL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for QuidelOrtho and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/08/2024Today6/17/2024Next Earnings (Estimated)8/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Diagnostic substances Sub-IndustryHealth Care Supplies Current SymbolNASDAQ:QDEL CUSIP74838J10 CIK353569 Webwww.quidel.com Phone(800) 874-1517Fax858-453-4338Employees7,100Year Founded1979Price Target and Rating Average Stock Price Target$59.00 High Stock Price Target$76.00 Low Stock Price Target$37.00 Potential Upside/Downside+62.5%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)($26.39) Trailing P/E RatioN/A Forward P/E Ratio19.63 P/E GrowthN/ANet Income$-10,100,000.00 Net Margins-61.65% Pretax Margin-65.95% Return on Equity3.96% Return on Assets2.24% Debt Debt-to-Equity Ratio0.68 Current Ratio1.55 Quick Ratio0.81 Sales & Book Value Annual Sales$3.00 billion Price / Sales0.81 Cash Flow$10.97 per share Price / Cash Flow3.31 Book Value$74.92 per share Price / Book0.48Miscellaneous Outstanding Shares66,970,000Free Float66,302,000Market Cap$2.43 billion OptionableOptionable Beta0.12 Social Links 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Joseph M. Busky CPA (Age 56)Chief Financial Officer Comp: $890.63kMr. Robert J. Bujarski J.D. (Age 55)Executive VP & COO Comp: $961.26kDr. Werner Kroll Ph.D. (Age 67)Senior Vice President of Research & Development Comp: $1.03MMr. Michael S. Iskra (Age 54)Executive VP & Chief Commercial Officer Comp: $870.93kMr. Brian J. Blaser (Age 59)President, CEO & Director Ms. Louise M. Brandy (Age 65)Chief Information Officer Ruben ArguetaDirector of Investor RelationsMs. Michelle A. Hodges J.D. (Age 61)Senior VP, General Counsel & Corporate Secretary Comp: $1.8MMr. William J. Ferenczy (Age 68)Point of Care Business Unit Leader Ms. Tamara A. Ranalli (Age 51)Molecular Diagnostics Business Unit Leader More ExecutivesKey CompetitorsMeridian BioscienceNASDAQ:VIVOHeskaNASDAQ:HSKADENTSPLY SIRONANASDAQ:XRAYMerit Medical SystemsNASDAQ:MMSIHaemoneticsNYSE:HAEView All CompetitorsInsiders & InstitutionsCarlyle Group Inc.Sold 64,263 sharesTotal: $2.59 M ($40.23/share)Teachers Retirement System of The State of KentuckySold 5,748 shares on 5/28/2024Ownership: 0.044%EMC Capital ManagementBought 2,441 shares on 5/20/2024Ownership: 0.004%Comerica BankSold 1,005 shares on 5/17/2024Ownership: 0.105%Tidal Investments LLCBought 12,147 shares on 5/17/2024Ownership: 0.018%View All Insider TransactionsView All Institutional Transactions QDEL Stock Analysis - Frequently Asked Questions Should I buy or sell QuidelOrtho stock right now? 7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for QuidelOrtho in the last year. There are currently 2 sell ratings, 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" QDEL shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in QDEL, but not buy additional shares or sell existing shares. View QDEL analyst ratings or view top-rated stocks. What is QuidelOrtho's stock price target for 2024? 7 brokers have issued 1-year target prices for QuidelOrtho's stock. Their QDEL share price targets range from $37.00 to $76.00. On average, they predict the company's stock price to reach $59.00 in the next twelve months. This suggests a possible upside of 62.5% from the stock's current price. View analysts price targets for QDEL or view top-rated stocks among Wall Street analysts. How have QDEL shares performed in 2024? QuidelOrtho's stock was trading at $73.70 on January 1st, 2024. Since then, QDEL shares have decreased by 50.7% and is now trading at $36.31. View the best growth stocks for 2024 here. When is QuidelOrtho's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 13th 2024. View our QDEL earnings forecast. How were QuidelOrtho's earnings last quarter? QuidelOrtho Co. (NASDAQ:QDEL) issued its quarterly earnings results on Wednesday, May, 8th. The company reported $0.36 earnings per share for the quarter, missing analysts' consensus estimates of $0.42 by $0.06. The business earned $711 million during the quarter, compared to analyst estimates of $697.33 million. QuidelOrtho had a negative net margin of 61.65% and a positive trailing twelve-month return on equity of 3.96%. What ETFs hold QuidelOrtho's stock? ETFs with the largest weight of QuidelOrtho (NASDAQ:QDEL) stock in their portfolio include Amplify Treatments, Testing and Advancements ETF (GERM), First Trust Health Care AlphaDEX Fund (FXH), SPDR S&P Health Care Equipment ETF (XHE), ROBO Global Healthcare Technology and Innovation ETF (HTEC), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD) and Ballast Small/Mid Cap ETF (MGMT).iShares U.S. Medical Devices ETF (IHI). What is Doug Bryant's approval rating as QuidelOrtho's CEO? 47 employees have rated QuidelOrtho Chief Executive Officer Doug Bryant on Glassdoor.com. Doug Bryant has an approval rating of 76% among the company's employees. What other stocks do shareholders of QuidelOrtho own? Based on aggregate information from My MarketBeat watchlists, some companies that other QuidelOrtho investors own include NVIDIA (NVDA), DocuSign (DOCU), Tesla (TSLA), PayPal (PYPL), Shopify (SHOP), Block (SQ), Teladoc Health (TDOC), Netflix (NFLX), Advanced Micro Devices (AMD) and Zoom Video Communications (ZM). Who are QuidelOrtho's major shareholders? QuidelOrtho's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (7.30%), LSV Asset Management (1.13%), Clearbridge Investments LLC (0.78%), Private Management Group Inc. (0.68%), Burgundy Asset Management Ltd. (0.35%) and Gagnon Securities LLC (0.33%). Insiders that own company stock include Carlyle Group Inc, Joseph M Busky and Mary Lake Ph D Polan. View institutional ownership trends. How do I buy shares of QuidelOrtho? Shares of QDEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:QDEL) was last updated on 6/17/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredInflation Is Robbing You Blind! Here’s How to Fight Back!Quietly, inflation has reduced your purchasing power by 29.4% since 2014. So something that cost $100 in 20...American Alternative | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredHow Biden has already won 2024Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that...Porter & Company | SponsoredBill Clinton Backing Biden Replacement???Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding QuidelOrtho Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share QuidelOrtho With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.